Search Results
Patient Selection and PARP Inhibitors in Ovarian Cancer
PARP Inhibitor Selection in Ovarian Cancer
Kondrashova O (2019): Improving patient selection for PARP inhibitors in ovarian cancer
PARP inhibitors in ovarian cancer: Clinical updates from SGO 2023
Ovarian Cancer: Selecting an Appropriate PARP Inhibitor
Dr. Backes on Treatment Selection With PARP Inhibitors in Ovarian Cancer
Evaluating future use of PARP inhibitors in neoadjuvant therapy for ovarian cancer
Identifying optimal patient subgroups in ovarian cancer for neoadjuvant PARP inhibitor therapy
Ovarian Cancer: Selecting Between Available PARPs
The promising potential of PARP inhibitors in ovarian cancer
Selecting patients to be treated with maintenance olaparib in the PAOLA-1 trial
Ongoing Clinical Trials with PARP Inhibitors in Ovarian Cancer
